Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Khiron Life Sciences Corp.
  6. News
  7. All News
    KHRN   CA49374L3065

KHIRON LIFE SCIENCES CORP.

(KHRN)
  Report
Delayed Bourse de Toronto  -  02:05:53 2023-02-01 pm EST
0.1500 CAD   -3.23%
01/19Khiron Life Sciences Starts Providing Insurance-covered Prescriptions in Colombia
MT
01/19Khiron begins dispensation of insurance-covered prescriptions in Colombia
PR
01/16Khiron Edging Up as Notes NHS Reimburses Cost of Cannabis Treatment to First Zerenia Clinics UK Patient
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about KHIRON LIFE SCIENCES CORP.
01/19Khiron Life Sciences Starts Providing Insurance-covered Prescriptions in Colombia
MT
01/19Khiron begins dispensation of insurance-covered prescriptions in Colombia
PR
01/16Khiron Edging Up as Notes NHS Reimburses Cost of Cannabis Treatment to First Zerenia Cl..
MT
01/16Khiron Life Sciences Corp. Announces Full Reimbursement by the NHS of Costs Associated ..
CI
01/16NHS reimburses the cost of cannabis treatment to the first Zerenia™ Clinics UK pa..
PR
01/09Khiron wins first medical cannabis contract with Colombia's largest public insurance co..
PR
01/09Khiron wins first medical cannabis contract with Colombia's largest public insurance co..
AQ
01/09Khiron Wins First Medical Cannabis Contract with Colombia's Largest Public Insurance Co..
CI
01/05Khiron Up 41% As Notes Government of Colombia Declares Mandatory Insurance Coverage for..
MT
01/05Government of Colombia Declares Mandatory Insurance Coverage for Medical Cannabis Produ..
PR
01/05Government of Colombia Declares Mandatory Insurance Coverage for Medical Cannabis Produ..
AQ
2022Khiron Life Sciences : Md&a q3 2022
PU
2022Transcript : Khiron Life Sciences Corp., Q3 2022 Earnings Call, Nov 30, 2022
CI
2022Khiron Life Sciences Reports Third Quarter 2022 Financial Results
PR
2022Khiron Life Sciences Reports Third Quarter 2022 Financial Results
AQ
2022Khiron Life Sciences Corp. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
2022Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022
AQ
2022Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022
PR
2022Khiron Begins Sales in Switzerland, Increases Offerings in Germany, UK
MT
2022Khiron Life Sciences Corp. Begins Sales in Switzerland and Expands Its Medical Cannabis..
CI
2022Khiron begins sales in Switzerland and expands its medical cannabis portfolio in German..
AQ
2022Khiron Life Sciences Awarded Best Latin American Cannabis Company at Benzinga Cannabis ..
MT
2022Khiron Life Sciences Awarded Best Latin American Cannabis Company at Benzinga Cannabis ..
AQ
2022Khiron Life Sciences Corp.'s Equity Buyback announced on September 9, 2021 has expired.
CI
2022Khiron Life Sciences Up 4% after Reporting Launch of New Cannabis Products in Europe
MT
2022Khiron, the Global Leader in Medical Cannabis Launches New Cannabis Products in Europe ..
PR
2022Khiron Launches New Cannabis Products in Europe Including Stellar Genetics from Califor..
CI
2022Transcript : Khiron Life Sciences Corp., Q2 2022 Earnings Call, Aug 29, 2022
CI
2022Khiron Life Sciences Second-Quarter Loss Narrows on Higher Sales
MT
2022Khiron Life Sciences Reports Second Quarter 2022 Financial Results
PR
2022Khiron Life Sciences Corp. Reports Earnings Results for the Second Quarter and Six Mont..
CI
2022Khiron Life Sciences Completes Acquisition Of Pharmadrug Production GmbH
AQ
2022Medical Cannabis Leader Khiron Opens Brazil's First Zerenia Clinic
AQ
2022Khiron Life Sciences Corp. Announces the Opening of Zerenia™ Clinic in Brazil, Rio..
CI
2022Khiron Life Sciences Closes Purchase of Pharmadrug Production
MT
2022Khiron Completes Acquisition of Pharmadrug Production GmbH, Establishing German Pharmac..
AQ
2022Khiron Life Sciences Corp. (TSXV:KHRN completed the acq..
CI
2022Khiron Life Sciences Corp. Announces CFO Changes
CI
2022Khiron Appoints Helen Bellwood (ACA) as Interim CFO
PR
2022Khiron Life Sciences Corp. - Medical Cannabis Leader Khiron Continues Global Expansion ..
AQ
2022Medical Cannabis Leader Khiron Continues Global Expansion into Spain
AQ
2022Khiron Life Sciences Corp. Continues Global Expansion into Spain
CI
2022Khiron Life Sciences Corp. - Medical Cannabis Innovator Khiron Continues Global Expansi..
AQ
2022Khiron Life Provides Update on Performance, Expansion in Europe, Latin America
MT
2022Khiron Life Sciences Corp. Brief: Says Continuing Globa..
MT
2022Medical Cannabis Innovator Khiron Continues Global Expansion as Industry Leader Through..
AQ
2022Khiron Life Sciences Announces Results of 2022 Annual General and Special Meeting
AQ
2022Khiron Life Sciences Corp. Announces Resignation of Deborah Rosati from the Board of Di..
CI
2022Transcript : Khiron Life Sciences Corp. - Special Call
CI
2022Khiron Life Sciences Completes Overnight Brokered Offering; Down 3.7%
MT
2022Khiron life sciences announces closing of $4.6 million overnight brokered offering incl..
AQ
2022IIROC Trading Resumption - KHRN
AQ
2022Khiron Life Sciences Prices $4 Million Overnight Brokered Offering
MT
2022Khiron life sciences announces pricing and size of overnight brokered offering
AQ
2022IIROC Trading Halt - KHRN
AQ
2022Khiron Life Sciences Details Overnight Brokered Offering
MT
2022Khiron life sciences announces overnight brokered offering
AQ
2022PharmaDrug Announces Execution Of an Agreement to Sell Its German Cannabis Asset to Khi..
AQ
2022Transcript : Khiron Life Sciences Corp., Q1 2022 Earnings Call, May 31, 2022
CI
2022Khiron Life Sciences to Buy EU-GMP-Certified German Pharmaceuticals Manufacturer and Wh..
MT
2022Khiron to Acquire EU-GMP-Certified German Pharmaceuticals Manufacturer and Wholesaler, ..
PR
2022Khiron Life Sciences : Financial Statements Q1 2022
PU
2022Khiron Life Sciences : Md&a q1 2022
PU
2022Khiron Life Sciences Reports First Quarter 2022 Financial Results with Record Revenue i..
PR
2022Khiron Life Sciences Reports First Quarter 2022 Financial Results with Record Revenue i..
AQ
2022Khiron Life Sciences Corp. Reports Earnings Results for the First Quarter Ended March 3..
CI
2022Khiron Life Sciences Corp. entered into an agreement to acquire Pharmadrug Production G..
CI
2022Khiron to Host First Quarter 2022 Conference Call on May 31, 2022
PR
2022Khiron achieves United Kingdom Cannabis Sales Volume Growth of 240% in Q1 2022
PR
2022Transcript : Khiron Life Sciences Corp., Q4 2021 Earnings Call, May 02, 2022
CI
2022Khiron Life Sciences Reports 2021 Fiscal Year End Results
PR
2022Khiron Life Sciences Corp. Provides Sales Guidance for the First Quarter of 2022
CI
2022Khiron Life Sciences : Ye 2021 md&a
PU
2022Khiron Life Sciences : YE 2021 Financial Statements
PU
2022Khiron Life Sciences : Aif 2021
PU
1  2  3  4  5  6Next
Upcoming event on KHIRON LIFE SCIENCES CORP.